1 Report Overview 1.1 Research Scope 1.2 Market Segment by Type 1.2.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Type 1.2.2 GMP 1.2.3 Non-GMP 1.3 Market Segment by Application 1.3.1 Global Pharmaceutical Intermediates Market Share by Application (2016 VS 2021 VS 2027) 1.3.2 Antibiotics 1.3.3 Antipyretic Analgesics 1.3.4 Vitamins 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Pharmaceutical Intermediates Market Size (2016-2027) 2.1.1 Global Pharmaceutical Intermediates Revenue (2016-2027) 2.1.2 Global Pharmaceutical Intermediates Sales (2016-2027) 2.2 Global Pharmaceutical Intermediates Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027 2.2.1 Global Pharmaceutical Intermediates Sales by Regions (2016-2021) 2.2.2 Global Pharmaceutical Intermediates Revenue by Regions (2016-2021) 2.3 Global Pharmaceutical Intermediates Market Size Forecast by Region 2.3.1 Global Pharmaceutical Intermediates Sales Forecast by Region (2022-2027) 2.3.2 Global Pharmaceutical Intermediates Revenue Forecast by Region (2022-2027) 2.4 Global Top Pharmaceutical Intermediates Regions (Countries) Ranking by Market Size 2.5 Pharmaceutical Intermediates Industry Trends 2.5.1 Pharmaceutical Intermediates Market Trends 2.5.2 Pharmaceutical Intermediates Market Drivers 2.5.3 Pharmaceutical Intermediates Market Challenges 2.5.4 Pharmaceutical Intermediates Market Restraints 3 Competitive Landscape by Manufacturers 3.1 Global Top Pharmaceutical Intermediates Manufacturers by Sales (2016-2021) 3.1.1 Global Pharmaceutical Intermediates Sales by Manufacturers (2016-2021) 3.1.2 Global Pharmaceutical Intermediates Sales Market Share by Manufacturers (2016-2021) 3.1.3 Global 5 and 10 Largest Manufacturers by Pharmaceutical Intermediates Sales in 2020 3.2 Global Top Manufacturers Pharmaceutical Intermediates by Revenue 3.2.1 Global Pharmaceutical Intermediates Revenue by Manufacturers (2016-2021) 3.2.2 Top Pharmaceutical Intermediates Manufacturers Covered: Ranking by Revenue 3.2.3 Global Pharmaceutical Intermediates Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Pharmaceutical Intermediates Market Concentration Ratio (CR5 and HHI) 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Intermediates as of 2020) 3.4 Global Pharmaceutical Intermediates Average Selling Price (ASP) by Manufacturers 3.5 Key Manufacturers Pharmaceutical Intermediates Plants/Factories Distribution and Area Served 3.6 Date of Key Manufacturers Enter into Pharmaceutical Intermediates Market 3.7 Key Manufacturers Pharmaceutical Intermediates Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Pharmaceutical Intermediates Market Size by Type 4.1 Global Pharmaceutical Intermediates Historic Market Review by Type (2016-2021) 4.1.1 Global Pharmaceutical Intermediates Sales Market Share by Type (2016-2021) 4.1.2 Global Pharmaceutical Intermediates Revenue Market Share by Type (2016-2021) 4.1.3 Pharmaceutical Intermediates Price by Type (2016-2021) 4.2 Global Pharmaceutical Intermediates Market Estimates and Forecasts by Type (2022-2027) 4.2.1 Global Pharmaceutical Intermediates Sales Forecast by Type (2022-2027) 4.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Type (2022-2027) 4.2.3 Pharmaceutical Intermediates Price Forecast by Type (2022-2027) 5 Global Pharmaceutical Intermediates Market Size by Application 5.1 Global Pharmaceutical Intermediates Historic Market Review by Application (2016-2021) 5.1.2 Global Pharmaceutical Intermediates Sales Market Share by Application (2016-2021) 5.1.3 Global Pharmaceutical Intermediates Revenue Market Share by Application (2016-2021) 5.1.4 Pharmaceutical Intermediates Price by Application (2016-2021) 5.2 Global Pharmaceutical Intermediates Market Estimates and Forecasts by Application (2022-2027) 5.2.2 Global Pharmaceutical Intermediates Sales Forecast by Application (2022-2027) 5.2.3 Global Pharmaceutical Intermediates Revenue Forecast by Application (2022-2027) 5.2.4 Pharmaceutical Intermediates Price Forecast by Application (2022-2027) 6 North America 6.1 North America Pharmaceutical Intermediates Sales Breakdown by Company 6.1.1 North America Pharmaceutical Intermediates Sales by Company (2016-2027) 6.1.2 North America Pharmaceutical Intermediates Revenue by Company (2016-2027) 6.2 North America Pharmaceutical Intermediates Market Size by Type (2016-2027) 6.2.1 North America Pharmaceutical Intermediates Sales by Type (2016-2027) 6.2.2 North America Pharmaceutical Intermediates Revenue by Type (2016-2027) 6.3 North America Pharmaceutical Intermediates Market Size by Application (2016-2027) 6.3.1 North America Pharmaceutical Intermediates Sales by Application (2016-2027) 6.3.2 North America Pharmaceutical Intermediates Revenue by Application (2016-2027) 6.4 North America Pharmaceutical Intermediates Market Size by Country 6.4.1 North America Pharmaceutical Intermediates Sales by Country (2016-2027) 6.4.2 North America Pharmaceutical Intermediates Revenue by Country (2016-2027) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Pharmaceutical Intermediates Sales Breakdown by Company 7.1.1 Europe Pharmaceutical Intermediates Sales by Company (2016-2027) 7.1.2 Europe Pharmaceutical Intermediates Revenue by Company (2016-2027) 7.2 Europe Pharmaceutical Intermediates Market Size by Type (2016-2027) 7.2.1 Europe Pharmaceutical Intermediates Sales by Type (2016-2027) 7.2.2 Europe Pharmaceutical Intermediates Revenue by Type (2016-2027) 7.3 Europe Pharmaceutical Intermediates Market Size by Application (2016-2027) 7.3.1 Europe Pharmaceutical Intermediates Sales by Application (2016-2027) 7.3.2 Europe Pharmaceutical Intermediates Revenue by Application (2016-2027) 7.4 Europe Pharmaceutical Intermediates Market Size by Country 7.4.1 Europe Pharmaceutical Intermediates Sales by Country (2016-2027) 7.4.2 Europe Pharmaceutical Intermediates Revenue by Country (2016-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 8 Asia Pacific 8.1 Asia Pacific Pharmaceutical Intermediates Sales Breakdown by Company 8.1.1 Asia Pacific Pharmaceutical Intermediates Sales by Company (2016-2027) 8.1.2 Asia Pacific Pharmaceutical Intermediates Revenue by Company (2016-2027) 8.2 Asia Pacific Pharmaceutical Intermediates Market Size by Type (2016-2027) 8.2.1 Asia Pacific Pharmaceutical Intermediates Sales by Type (2016-2027) 8.2.2 Asia Pacific Pharmaceutical Intermediates Revenue by Type (2016-2027) 8.3 Asia Pacific Pharmaceutical Intermediates Market Size by Application (2016-2027) 8.3.1 Asia Pacific Pharmaceutical Intermediates Sales by Application (2016-2027) 8.3.2 Asia Pacific Pharmaceutical Intermediates Revenue by Application (2016-2027) 8.4 Asia Pacific Pharmaceutical Intermediates Market Size by Regions 8.4.1 Asia Pacific Pharmaceutical Intermediates Sales by Regions 8.4.2 Asia Pacific Pharmaceutical Intermediates Revenue by Regions 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 India 8.4.7 Australia 8.4.8 Taiwan 8.4.9 Indonesia 8.4.10 Thailand 8.4.11 Malaysia 8.4.12 Philippines 8.4.13 Vietnam 9 Latin America 9.1 Latin America Pharmaceutical Intermediates Sales Breakdown by Company 9.1.1 Latin America Pharmaceutical Intermediates Sales by Company (2016-2027) 9.1.2 Latin America Pharmaceutical Intermediates Revenue by Company (2016-2027) 9.2 Latin America Pharmaceutical Intermediates Market Size by Type (2016-2027) 9.2.1 Latin America Pharmaceutical Intermediates Sales by Type (2016-2027) 9.2.2 Latin America Pharmaceutical Intermediates Revenue by Type (2016-2027) 9.3 Latin America Pharmaceutical Intermediates Market Size by Application (2016-2027) 9.3.1 Latin America Pharmaceutical Intermediates Sales by Application (2016-2027) 9.3.2 Latin America Pharmaceutical Intermediates Revenue by Application (2016-2027) 9.4 Latin America Pharmaceutical Intermediates Market Size by Country 9.4.1 Latin America Pharmaceutical Intermediates Sales by Country (2016-2027) 9.4.2 Latin America Pharmaceutical Intermediates Revenue by Country (2016-2027) 9.4.3 Mexico 9.4.4 Brazil 9.4.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Pharmaceutical Intermediates Sales Breakdown by Company 10.1.1 Middle East and Africa Pharmaceutical Intermediates Sales by Company (2016-2027) 10.1.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Company (2016-2027) 10.2 Middle East and Africa Pharmaceutical Intermediates Market Size by Type (2016-2027) 10.2.1 Middle East and Africa Pharmaceutical Intermediates Sales by Type (2016-2027) 10.2.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Type (2016-2027) 10.3 Middle East and Africa Pharmaceutical Intermediates Market Size by Application (2016-2027) 10.3.1 Middle East and Africa Pharmaceutical Intermediates Sales by Application (2016-2027) 10.3.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Application (2016-2027) 10.4 Middle East and Africa Pharmaceutical Intermediates Market Size by Country 10.4.1 Middle East and Africa Pharmaceutical Intermediates Sales by Country (2016-2027) 10.4.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2016-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 U.A.E 11 Company Profiles 11.1 Lonza 11.1.1 Lonza Corporation Information 11.1.2 Lonza Overview 11.1.3 Lonza Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021) 11.1.4 Lonza Pharmaceutical Intermediates Products and Services 11.1.5 Lonza Pharmaceutical Intermediates SWOT Analysis 11.1.6 Lonza Recent Developments 11.2 Catalent 11.2.1 Catalent Corporation Information 11.2.2 Catalent Overview 11.2.3 Catalent Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021) 11.2.4 Catalent Pharmaceutical Intermediates Products and Services 11.2.5 Catalent Pharmaceutical Intermediates SWOT Analysis 11.2.6 Catalent Recent Developments 11.3 Patheon 11.3.1 Patheon Corporation Information 11.3.2 Patheon Overview 11.3.3 Patheon Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021) 11.3.4 Patheon Pharmaceutical Intermediates Products and Services 11.3.5 Patheon Pharmaceutical Intermediates SWOT Analysis 11.3.6 Patheon Recent Developments 11.4 Jubilant 11.4.1 Jubilant Corporation Information 11.4.2 Jubilant Overview 11.4.3 Jubilant Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021) 11.4.4 Jubilant Pharmaceutical Intermediates Products and Services 11.4.5 Jubilant Pharmaceutical Intermediates SWOT Analysis 11.4.6 Jubilant Recent Developments 11.5 Granules 11.5.1 Granules Corporation Information 11.5.2 Granules Overview 11.5.3 Granules Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021) 11.5.4 Granules Pharmaceutical Intermediates Products and Services 11.5.5 Granules Pharmaceutical Intermediates SWOT Analysis 11.5.6 Granules Recent Developments 11.6 Ganesh 11.6.1 Ganesh Corporation Information 11.6.2 Ganesh Overview 11.6.3 Ganesh Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021) 11.6.4 Ganesh Pharmaceutical Intermediates Products and Services 11.6.5 Ganesh Pharmaceutical Intermediates SWOT Analysis 11.6.6 Ganesh Recent Developments 11.7 Chemcon 11.7.1 Chemcon Corporation Information 11.7.2 Chemcon Overview 11.7.3 Chemcon Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021) 11.7.4 Chemcon Pharmaceutical Intermediates Products and Services 11.7.5 Chemcon Pharmaceutical Intermediates SWOT Analysis 11.7.6 Chemcon Recent Developments 11.8 BASF 11.8.1 BASF Corporation Information 11.8.2 BASF Overview 11.8.3 BASF Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021) 11.8.4 BASF Pharmaceutical Intermediates Products and Services 11.8.5 BASF Pharmaceutical Intermediates SWOT Analysis 11.8.6 BASF Recent Developments 11.9 Porton 11.9.1 Porton Corporation Information 11.9.2 Porton Overview 11.9.3 Porton Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021) 11.9.4 Porton Pharmaceutical Intermediates Products and Services 11.9.5 Porton Pharmaceutical Intermediates SWOT Analysis 11.9.6 Porton Recent Developments 11.10 Lianhetech 11.10.1 Lianhetech Corporation Information 11.10.2 Lianhetech Overview 11.10.3 Lianhetech Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021) 11.10.4 Lianhetech Pharmaceutical Intermediates Products and Services 11.10.5 Lianhetech Pharmaceutical Intermediates SWOT Analysis 11.10.6 Lianhetech Recent Developments 11.11 ABA Chem 11.11.1 ABA Chem Corporation Information 11.11.2 ABA Chem Overview 11.11.3 ABA Chem Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021) 11.11.4 ABA Chem Pharmaceutical Intermediates Products and Services 11.11.5 ABA Chem Recent Developments 11.12 Tianma 11.12.1 Tianma Corporation Information 11.12.2 Tianma Overview 11.12.3 Tianma Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021) 11.12.4 Tianma Pharmaceutical Intermediates Products and Services 11.12.5 Tianma Recent Developments 11.13 Jiujiujiu 11.13.1 Jiujiujiu Corporation Information 11.13.2 Jiujiujiu Overview 11.13.3 Jiujiujiu Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021) 11.13.4 Jiujiujiu Pharmaceutical Intermediates Products and Services 11.13.5 Jiujiujiu Recent Developments 11.14 Alpha 11.14.1 Alpha Corporation Information 11.14.2 Alpha Overview 11.14.3 Alpha Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021) 11.14.4 Alpha Pharmaceutical Intermediates Products and Services 11.14.5 Alpha Recent Developments 11.15 Jiuzhou 11.15.1 Jiuzhou Corporation Information 11.15.2 Jiuzhou Overview 11.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021) 11.15.4 Jiuzhou Pharmaceutical Intermediates Products and Services 11.15.5 Jiuzhou Recent Developments 11.16 Yongtai 11.16.1 Yongtai Corporation Information 11.16.2 Yongtai Overview 11.16.3 Yongtai Pharmaceutical Intermediates Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021) 11.16.4 Yongtai Pharmaceutical Intermediates Products and Services 11.16.5 Yongtai Recent Developments 12 Value Chain and Sales Channels Analysis 12.1 Pharmaceutical Intermediates Value Chain Analysis 12.2 Pharmaceutical Intermediates Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Pharmaceutical Intermediates Production Mode & Process 12.4 Pharmaceutical Intermediates Sales and Marketing 12.4.1 Pharmaceutical Intermediates Sales Channels 12.4.2 Pharmaceutical Intermediates Distributors 12.5 Pharmaceutical Intermediates Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Global Pharmaceutical Intermediates Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of GMP Table 3. Major Manufacturers of Non-GMP Table 4. Global Pharmaceutical Intermediates Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 5. Global Market Pharmaceutical Intermediates Market Size (US$ Million) by Region: 2016 VS 2021 VS 2027 Table 6. Global Pharmaceutical Intermediates Sales by Region (2016-2021) & (K MT) Table 7. Global Pharmaceutical Intermediates Sales Market Share by Region (2016-2021) Table 8. Global Pharmaceutical Intermediates Revenue by Region (2016-2021) & (US$ Million) Table 9. Global Pharmaceutical Intermediates Revenue Market Share by Region (2016-2021) Table 10. Global Pharmaceutical Intermediates Sales Forecast by Region (2022-2027) & (K MT) Table 11. Global Pharmaceutical Intermediates Sales Market Share Forecast by Region (2022-2027) Table 12. Global Pharmaceutical Intermediates Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Pharmaceutical Intermediates Revenue Market Share Forecast by Region (2022-2027) Table 14. Top Pharmaceutical Intermediates Regions (Countries) Ranking by Market Size (US$ Million) in 2020 Table 15. Pharmaceutical Intermediates Market Trends Table 16. Pharmaceutical Intermediates Market Drivers Table 17. Pharmaceutical Intermediates Market Challenges Table 18. Pharmaceutical Intermediates Market Restraints Table 19. Global Pharmaceutical Intermediates Sales by Manufacturers (2016-2021) & (K MT) Table 20. Global Pharmaceutical Intermediates Sales Share by Manufacturers (2016-2021) Table 21. Global Pharmaceutical Intermediates Revenue by Manufacturers (2016-2021) & (US$ Million) Table 22. Ranking of Global Top Pharmaceutical Intermediates Manufacturers by Revenue (US$ Million) in 2020 Table 23. Pharmaceutical Intermediates Revenue Share by Manufacturers (2016-2021) Table 24. Global Pharmaceutical Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI) Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Intermediates as of 2020) Table 26. Key Manufacturers Pharmaceutical Intermediates Average Selling Price (ASP) & (2016-2021) & (USD/MT) Table 27. Key Manufacturers Pharmaceutical Intermediates Plants/Factories Distribution Table 28. Key Manufacturers Pharmaceutical Intermediates Area Served Table 29. Date of Key Manufacturers Enter into Pharmaceutical Intermediates Market Table 30. Key Manufacturers Pharmaceutical Intermediates Product Type Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global Pharmaceutical Intermediates Sales (K MT) by Type (2016-2021) Table 33. Global Pharmaceutical Intermediates Sales Share by Type (2016-2021) Table 34. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Type (2016-2021) Table 35. Global Pharmaceutical Intermediates Price (K MT) by Type (2016-2021) Table 36. Global Pharmaceutical Intermediates Sales (K MT) by Type (2022-2027) Table 37. Global Pharmaceutical Intermediates Sales Share by Type (2022-2027) Table 38. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Type (2022-2027) Table 39. Global Pharmaceutical Intermediates Revenue Share by Type (2022-2027) Table 40. Global Pharmaceutical Intermediates Price (K MT) by Type (2022-2027) Table 41. Global Pharmaceutical Intermediates Sales (K MT) by Application (2016-2021) Table 42. Global Pharmaceutical Intermediates Sales Share by Application (2016-2021) Table 43. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Application (2016-2021) Table 44. Global Pharmaceutical Intermediates Price (K MT) by Application (2016-2021) Table 45. Global Pharmaceutical Intermediates Sales (K MT) by Application (2022-2027) Table 46. Global Pharmaceutical Intermediates Sales Share by Application (2022-2027) Table 47. Global Pharmaceutical Intermediates Revenue (US$ Million) Market Share by Application (2022-2027) Table 48. Global Pharmaceutical Intermediates Revenue Share by Application (2022-2027) Table 49. Global Pharmaceutical Intermediates Price (K MT) by Application (2022-2027) Table 50. North America Pharmaceutical Intermediates Sales by Company (2016-2021) & (K MT) Table 51. North America Pharmaceutical Intermediates Sales Market Share by Company (2016-2021) Table 52. North America Pharmaceutical Intermediates Revenue by Company (2016-2021) & (US$ Million) Table 53. North America Pharmaceutical Intermediates Revenue Market Share by Company (2016-2021) Table 54. North America Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT) Table 55. North America Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT) Table 56. North America Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million) Table 57. North America Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million) Table 58. North America Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT) Table 59. North America Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT) Table 60. North America Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million) Table 61. North America Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million) Table 62. North America Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT) Table 63. North America Pharmaceutical Intermediates Sales by Country (2022-2027) & (K MT) Table 64. North America Pharmaceutical Intermediates Revenue by Country (2016-2021) & (US$ Million) Table 65. North America Pharmaceutical Intermediates Revenue by Country (2022-2027) & (US$ Million) Table 66. Europe Pharmaceutical Intermediates Sales by Company (2016-2021) & (K MT) Table 67. Europe Pharmaceutical Intermediates Sales Market Share by Company (2016-2021) Table 68. Europe Pharmaceutical Intermediates Revenue by Company (2016-2021) & (US$ Million) Table 69. Europe Pharmaceutical Intermediates Revenue Market Share by Company (2016-2021) Table 70. Europe Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT) Table 71. Europe Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT) Table 72. Europe Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million) Table 73. Europe Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million) Table 74. Europe Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT) Table 75. Europe Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT) Table 76. Europe Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million) Table 77. Europe Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million) Table 78. Europe Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT) Table 79. Europe Pharmaceutical Intermediates Sales by Country (2022-2027) & (K MT) Table 80. Europe Pharmaceutical Intermediates Revenue by Country (2016-2021) & (US$ Million) Table 81. Europe Pharmaceutical Intermediates Revenue by Country (2022-2027) & (US$ Million) Table 82. Asia Pacific Pharmaceutical Intermediates Sales by Company (2016-2021) & (K MT) Table 83. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Company (2016-2021) Table 84. Asia Pacific Pharmaceutical Intermediates Revenue by Company (2016-2021) & (US$ Million) Table 85. Asia Pacific Pharmaceutical Intermediates Revenue Market Share by Company (2016-2021) Table 86. Asia Pacific Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT) Table 87. Asia Pacific Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT) Table 88. Asia Pacific Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million) Table 89. Asia Pacific Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million) Table 90. Asia Pacific Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT) Table 91. Asia Pacific Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT) Table 92. Asia Pacific Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million) Table 93. Asia Pacific Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million) Table 94. Asia Pacific Pharmaceutical Intermediates Sales by Region (2016-2021) & (K MT) Table 95. Asia Pacific Pharmaceutical Intermediates Sales by Region (2022-2027) & (K MT) Table 96. Asia Pacific Pharmaceutical Intermediates Revenue by Region (2016-2021) & (US$ Million) Table 97. Asia Pacific Pharmaceutical Intermediates Revenue by Region (2022-2027) & (US$ Million) Table 98. Latin America Pharmaceutical Intermediates Sales by Company (2016-2021) & (K MT) Table 99. Latin America Pharmaceutical Intermediates Sales Market Share by Company (2016-2021) Table 100. Latin America Pharmaceutical Intermediates Revenue by Company (2016-2021) & (US$ Million) Table 101. Latin America Pharmaceutical Intermediates Revenue Market Share by Company (2016-2021) Table 102. Latin America Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT) Table 103. Latin America Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT) Table 104. Latin America Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million) Table 105. Latin America Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million) Table 106. Latin America Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT) Table 107. Latin America Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT) Table 108. Latin America Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million) Table 109. Latin America Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million) Table 110. Latin America Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT) Table 111. Latin America Pharmaceutical Intermediates Sales by Country (2022-2027) & (K MT) Table 112. Latin America Pharmaceutical Intermediates Revenue by Country (2016-2021) & (US$ Million) Table 113. Latin America Pharmaceutical Intermediates Revenue by Country (2022-2027) & (US$ Million) Table 114. Middle East and Africa Pharmaceutical Intermediates Sales by Company (2016-2021) & (K MT) Table 115. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Company (2016-2021) Table 116. Middle East and Africa Pharmaceutical Intermediates Revenue by Company (2016-2021) & (US$ Million) Table 117. Middle East and Africa Pharmaceutical Intermediates Revenue Market Share by Company (2016-2021) Table 118. Middle East and Africa Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT) Table 119. Middle East and Africa Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT) Table 120. Middle East and Africa Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million) Table 121. Middle East and Africa Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million) Table 122. Middle East and Africa Pharmaceutical Intermediates Sales by Application (2016-2021) & (K MT) Table 123. Middle East and Africa Pharmaceutical Intermediates Sales by Application (2022-2027) & (K MT) Table 124. Middle East and Africa Pharmaceutical Intermediates Revenue by Application (2016-2021) & (US$ Million) Table 125. Middle East and Africa Pharmaceutical Intermediates Revenue by Application (2022-2027) & (US$ Million) Table 126. Middle East and Africa Pharmaceutical Intermediates Sales by Country (2016-2021) & (K MT) Table 127. Middle East and Africa Pharmaceutical Intermediates Sales by Country (2022-2027) & (K MT) Table 128. Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2016-2021) & (US$ Million) Table 129. Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2022-2027) & (US$ Million) Table 130. Lonza Corporation Information Table 131. Lonza Description and Overview Table 132. Lonza Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021) Table 133. Lonza Pharmaceutical Intermediates Product and Services Table 134. Lonza Pharmaceutical Intermediates SWOT Analysis Table 135. Lonza Recent Developments Table 136. Catalent Corporation Information Table 137. Catalent Description and Overview Table 138. Catalent Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021) Table 139. Catalent Pharmaceutical Intermediates Product and Services Table 140. Catalent Pharmaceutical Intermediates SWOT Analysis Table 141. Catalent Recent Developments Table 142. Patheon Corporation Information Table 143. Patheon Description and Overview Table 144. Patheon Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021) Table 145. Patheon Pharmaceutical Intermediates Product and Services Table 146. Patheon Pharmaceutical Intermediates SWOT Analysis Table 147. Patheon Recent Developments Table 148. Jubilant Corporation Information Table 149. Jubilant Description and Overview Table 150. Jubilant Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021) Table 151. Jubilant Pharmaceutical Intermediates Product and Services Table 152. Jubilant Pharmaceutical Intermediates SWOT Analysis Table 153. Jubilant Recent Developments Table 154. Granules Corporation Information Table 155. Granules Description and Overview Table 156. Granules Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021) Table 157. Granules Pharmaceutical Intermediates Product and Services Table 158. Granules Pharmaceutical Intermediates SWOT Analysis Table 159. Granules Recent Developments Table 160. Ganesh Corporation Information Table 161. Ganesh Description and Overview Table 162. Ganesh Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021) Table 163. Ganesh Pharmaceutical Intermediates Product and Services Table 164. Ganesh Pharmaceutical Intermediates SWOT Analysis Table 165. Ganesh Recent Developments Table 166. Chemcon Corporation Information Table 167. Chemcon Description and Overview Table 168. Chemcon Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021) Table 169. Chemcon Pharmaceutical Intermediates Product and Services Table 170. Chemcon Pharmaceutical Intermediates SWOT Analysis Table 171. Chemcon Recent Developments Table 172. BASF Corporation Information Table 173. BASF Description and Overview Table 174. BASF Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021) Table 175. BASF Pharmaceutical Intermediates Product and Services Table 176. BASF Pharmaceutical Intermediates SWOT Analysis Table 177. BASF Recent Developments Table 178. Porton Corporation Information Table 179. Porton Description and Overview Table 180. Porton Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021) Table 181. Porton Pharmaceutical Intermediates Product and Services Table 182. Porton Pharmaceutical Intermediates SWOT Analysis Table 183. Porton Recent Developments Table 184. Lianhetech Corporation Information Table 185. Lianhetech Description and Overview Table 186. Lianhetech Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021) Table 187. Lianhetech Pharmaceutical Intermediates Product and Services Table 188. Lianhetech Pharmaceutical Intermediates SWOT Analysis Table 189. Lianhetech Recent Developments Table 190. ABA Chem Corporation Information Table 191. ABA Chem Description and Overview Table 192. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021) Table 193. ABA Chem Pharmaceutical Intermediates Product and Services Table 194. ABA Chem Recent Developments Table 195. Tianma Corporation Information Table 196. Tianma Description and Overview Table 197. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021) Table 198. Tianma Pharmaceutical Intermediates Product and Services Table 199. Tianma Recent Developments Table 200. Jiujiujiu Corporation Information Table 201. Jiujiujiu Description and Overview Table 202. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021) Table 203. Jiujiujiu Pharmaceutical Intermediates Product and Services Table 204. Jiujiujiu Recent Developments Table 205. Alpha Corporation Information Table 206. Alpha Description and Overview Table 207. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021) Table 208. Alpha Pharmaceutical Intermediates Product and Services Table 209. Alpha Recent Developments Table 210. Jiuzhou Corporation Information Table 211. Jiuzhou Description and Overview Table 212. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021) Table 213. Jiuzhou Pharmaceutical Intermediates Product and Services Table 214. Jiuzhou Recent Developments Table 215. Yongtai Corporation Information Table 216. Yongtai Description and Overview Table 217. Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue (Million US$), Average Selling Price (ASP) (USD/MT) and Gross Margin (2016-2021) Table 218. Yongtai Pharmaceutical Intermediates Product and Services Table 219. Yongtai Recent Developments Table 220. Key Raw Materials Lists Table 221. Raw Materials Key Suppliers Lists Table 222. Pharmaceutical Intermediates Distributors List Table 223. Pharmaceutical Intermediates Customers List Table 224. Research Programs/Design for This Report Table 225. Key Data Information from Secondary Sources Table 226. Key Data Information from Primary Sources List of Figures Figure 1. Pharmaceutical Intermediates Product Picture Figure 2. Global Pharmaceutical Intermediates Sales Market Share by Type in 2020 & 2027 Figure 3. GMP Picture Figure 4. Non-GMP Picture Figure 5. Global Pharmaceutical Intermediates Sales Market Share by Application in 2020 & 2027 Figure 6. Antibiotics Use Case Figure 7. Antipyretic Analgesics Use Case Figure 8. Vitamins Use Case Figure 9. Others Use Case Figure 10. Pharmaceutical Intermediates Report Years Considered Figure 11. Global Pharmaceutical Intermediates Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Pharmaceutical Intermediates Market Size 2016-2027 (US$ Million) Figure 13. Global Pharmaceutical Intermediates Sales (2016-2021) & (K MT) Figure 14. Global Pharmaceutical Intermediates Market Size Market Share by Region: 2020 VS 2027 Figure 15. Global Pharmaceutical Intermediates Sales Market Share by Region (2016-2021) Figure 16. Global Pharmaceutical Intermediates Sales Market Share by Region in 2020 Figure 17. Global Pharmaceutical Intermediates Revenue Market Share by Region in 2016 VS 2020 Figure 18. Global Pharmaceutical Intermediates Sales Share by Manufacturers In 2020 Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Pharmaceutical Intermediates Sales in 2020 Figure 20. Pharmaceutical Intermediates Revenue Share by Manufacturers In 2020 Figure 21. Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 22. Global Pharmaceutical Intermediates Revenue Share by Type (2016-2021) Figure 23. Global Pharmaceutical Intermediates Revenue Growth Rate by Type in 2016 & 2020 Figure 24. Global Pharmaceutical Intermediates Revenue Share by Application (2016-2021) Figure 25. Global Pharmaceutical Intermediates Revenue Growth Rate by Application in 2016 & 2020 Figure 26. North America Pharmaceutical Intermediates Sales Market Share by Type (2016-2027) Figure 27. North America Pharmaceutical Intermediates Revenue Market Share by Type (2016-2027) Figure 28. North America Pharmaceutical Intermediates Sales Market Share by Application (2016-2027) Figure 29. North America Pharmaceutical Intermediates Revenue Market Share by Application (2016-2027) Figure 30. North America Pharmaceutical Intermediates Sales Share by Country (2016-2027) Figure 31. North America Pharmaceutical Intermediates Revenue Share by Country (2016-2027) Figure 32. U.S. Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 33. Canada Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 34. Europe Pharmaceutical Intermediates Sales Market Share by Type (2016-2027) Figure 35. Europe Pharmaceutical Intermediates Revenue Market Share by Type (2016-2027) Figure 36. Europe Pharmaceutical Intermediates Sales Market Share by Application (2016-2027) Figure 37. Europe Pharmaceutical Intermediates Revenue Market Share by Application (2016-2027) Figure 38. Europe Pharmaceutical Intermediates Sales Share by Country (2016-2027) Figure 39. Europe Pharmaceutical Intermediates Revenue Share by Country (2016-2027) Figure 40. Germany Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 41. France Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 42. U.K. Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 43. Italy Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 44. Russia Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 45. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Type (2016-2027) Figure 46. Asia Pacific Pharmaceutical Intermediates Revenue Market Share by Type (2016-2027) Figure 47. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Application (2016-2027) Figure 48. Asia Pacific Pharmaceutical Intermediates Revenue Market Share by Application (2016-2027) Figure 49. Asia Pacific Pharmaceutical Intermediates Sales Share by Region (2016-2027) Figure 50. Asia Pacific Pharmaceutical Intermediates Revenue Share by Region (2016-2027) Figure 51. China Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 52. Japan Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 53. South Korea Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 54. India Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 55. Australia Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 56. Taiwan Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 57. Indonesia Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 58. Thailand Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 59. Malaysia Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 60. Philippines Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 61. Vietnam Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 62. Latin America Pharmaceutical Intermediates Sales Market Share by Type (2016-2027) Figure 63. Latin America Pharmaceutical Intermediates Revenue Market Share by Type (2016-2027) Figure 64. Latin America Pharmaceutical Intermediates Sales Market Share by Application (2016-2027) Figure 65. Latin America Pharmaceutical Intermediates Revenue Market Share by Application (2016-2027) Figure 66. Latin America Pharmaceutical Intermediates Sales Share by Country (2016-2027) Figure 67. Latin America Pharmaceutical Intermediates Revenue Share by Country (2016-2027) Figure 68. Mexico Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 69. Brazil Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 70. Argentina Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 71. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Type (2016-2027) Figure 72. Middle East and Africa Pharmaceutical Intermediates Revenue Market Share by Type (2016-2027) Figure 73. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Application (2016-2027) Figure 74. Middle East and Africa Pharmaceutical Intermediates Revenue Market Share by Application (2016-2027) Figure 75. Middle East and Africa Pharmaceutical Intermediates Sales Share by Country (2016-2027) Figure 76. Middle East and Africa Pharmaceutical Intermediates Revenue Share by Country (2016-2027) Figure 77. Turkey Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 78. Saudi Arabia Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 79. U.A.E Pharmaceutical Intermediates Revenue (2016-2027) & (US$ Million) Figure 80. Pharmaceutical Intermediates Value Chain Figure 81. Pharmaceutical Intermediates Production Process Figure 82. Channels of Distribution Figure 83. Distributors Profiles Figure 84. Bottom-up and Top-down Approaches for This Report Figure 85. Data Triangulation Figure 86. Key Executives Interviewed

Lonza Catalent Patheon Jubilant Granules Ganesh Chemcon BASF Porton Lianhetech ABA Chem Tianma Jiujiujiu Alpha Jiuzhou Yongtai